Implant Insertion Procedure of the Port Delivery System With Ranibizumab : Overview and Clinical Pearls

OBJECTIVE: To describe the Port Delivery System with ranibizumab implant insertion procedure

Bibliographische Detailangaben
Veröffentlicht in:Ophthalmic surgery, lasers & imaging retina. - 2013. - 53(2022), 5 vom: 29. Mai, Seite 249-256
1. Verfasser: Pieramici, Dante J (VerfasserIn)
Weitere Verfasser: Wieland, Mark R, Stewart, Jay M, Chang, Robert T, Gune, Shamika A, Malhotra, Varun K, Barteselli, Giulio, Awh, Carl C
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2022
Zugriff auf das übergeordnete Werk:Ophthalmic surgery, lasers & imaging retina
Schlagworte:Journal Article Research Support, Non-U.S. Gov't Ranibizumab ZL1R02VT79
LEADER 01000naa a22002652 4500
001 NLM340985887
003 DE-627
005 20231226010726.0
007 cr uuu---uuuuu
008 231226s2022 xx |||||o 00| ||eng c
024 7 |a 10.3928/23258160-20220408-01  |2 doi 
028 5 2 |a pubmed24n1136.xml 
035 |a (DE-627)NLM340985887 
035 |a (NLM)35575736 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Pieramici, Dante J  |e verfasserin  |4 aut 
245 1 0 |a Implant Insertion Procedure of the Port Delivery System With Ranibizumab  |b Overview and Clinical Pearls 
264 1 |c 2022 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 19.05.2022 
500 |a Date Revised 20.05.2022 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a OBJECTIVE: To describe the Port Delivery System with ranibizumab implant insertion procedure 
520 |a METHODS: A surgical procedure based on the clinical trial program in patients with retinal diseases 
520 |a RESULTS: An infusion line is placed in the infero-temporal quadrant; a superotemporal quadrant corneal traction suture is recommended. The superotemporal quadrant peritomy of 6 × 6 mm is executed with gentle, purposeful tissue handling. Generous posterior and lateral sub-Tenon's capsule dissection creates laxity for the subsequent closure. Adequate scleral hemostasis is achieved with wet-field cautery to maintain a clean field. The implant is filled under magnification with a customized formulation of ranibizumab. A precise 3.5-mm-long scleral incision (4 mm posterior and parallel to the limbus) is created to ensure proper implant fit. The exposed pars plana undergoes laser ablation to reduce vitreous hemorrhage risk. A pars plana incision is made, and the implant is inserted perpendicular to the globe and seated flush against the sclera. Complete closure of both the conjunctiva and Tenon's capsule with scleral anchoring and mild tissue overhang at the anterior limbus is performed to reduce conjunctival erosion and retraction risks 
520 |a CONCLUSION: The procedure is straightforward yet requires precise preoperative and intraoperative preparation and standardized surgical techniques. [Ophthalmic Surg Lasers Imaging Retina. 2022;53:249-256.] 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 7 |a Ranibizumab  |2 NLM 
650 7 |a ZL1R02VT79  |2 NLM 
700 1 |a Wieland, Mark R  |e verfasserin  |4 aut 
700 1 |a Stewart, Jay M  |e verfasserin  |4 aut 
700 1 |a Chang, Robert T  |e verfasserin  |4 aut 
700 1 |a Gune, Shamika A  |e verfasserin  |4 aut 
700 1 |a Malhotra, Varun K  |e verfasserin  |4 aut 
700 1 |a Barteselli, Giulio  |e verfasserin  |4 aut 
700 1 |a Awh, Carl C  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Ophthalmic surgery, lasers & imaging retina  |d 2013  |g 53(2022), 5 vom: 29. Mai, Seite 249-256  |w (DE-627)NLM224956647  |x 2325-8179  |7 nnns 
773 1 8 |g volume:53  |g year:2022  |g number:5  |g day:29  |g month:05  |g pages:249-256 
856 4 0 |u http://dx.doi.org/10.3928/23258160-20220408-01  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_24 
912 |a GBV_ILN_31 
912 |a GBV_ILN_40 
912 |a GBV_ILN_63 
912 |a GBV_ILN_65 
912 |a GBV_ILN_69 
912 |a GBV_ILN_70 
912 |a GBV_ILN_90 
912 |a GBV_ILN_91 
912 |a GBV_ILN_130 
912 |a GBV_ILN_135 
912 |a GBV_ILN_136 
912 |a GBV_ILN_151 
912 |a GBV_ILN_181 
912 |a GBV_ILN_203 
912 |a GBV_ILN_217 
912 |a GBV_ILN_235 
912 |a GBV_ILN_289 
912 |a GBV_ILN_294 
912 |a GBV_ILN_297 
912 |a GBV_ILN_350 
912 |a GBV_ILN_352 
912 |a GBV_ILN_674 
912 |a GBV_ILN_676 
912 |a GBV_ILN_688 
912 |a GBV_ILN_698 
912 |a GBV_ILN_721 
912 |a GBV_ILN_737 
912 |a GBV_ILN_791 
912 |a GBV_ILN_812 
951 |a AR 
952 |d 53  |j 2022  |e 5  |b 29  |c 05  |h 249-256